Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
appointed, atezolizumab, Azitra, BA, Beloff, bridging, Carnegie, CFO, College, concurrent, Danforth, DGCL, discontinue, discontinued, discontinuing, doctrine, duty, enumerated, fiduciary, fullest, Gregg, IP, JD, lymphoma, MBA, Mellon, Middlebury, monotherapy, Pittsburgh, randomized, Repair, School, serving, Shegog, solid, successor, Tecentriq, thereunder, Todd, Trucode, University, waived
Removed:
AB, Acer, Aeglea, AG, ApS, Bausch, behavioral, Cognition, cognitive, coma, consistency, cycle, discouraging, encephalopathy, expedited, Food, hepatic, Horizon, Kaleido, liver, Mallinckrodt, neurocognitive, Pharma, plc, Rebiotix, Selecta, tolerability, Translate, UCD, Ultragenyx, Umecrine, urea
Filing tables
Filing exhibits
Associated SYBX transcripts
SYBX similar filings
Filing view
External links